Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progenitor Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06294691
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases

Who this might be right for
Acute Graft-versus-host Disease
Anhui Provincial Hospital 198
Testing effectiveness (Phase 2)Ended earlyNCT02983097
What this trial is testing

Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma Grade III (FL III°)Mantle Cell Lymphoma (MCL), Blastoid Variant+2 more
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 34
Testing effectiveness (Phase 2)WithdrawnNCT01001780
What this trial is testing

Pentostatin, Cyclophosphamide Plus Rituximab (PCR) for the Therapy of Poor-Prognosis Chronic Graft-Versus-Host Disease

Who this might be right for
Active Chronic Graft Versus Host Disease
University of Rochester
Not applicableLooking for participantsNCT02129543
What this trial is testing

Immune Reconstitution in Stem Cell Transplant Recipients

Who this might be right for
Cancer
University of Miami 700
Large-scale testing (Phase 3)Study completedNCT03930615
What this trial is testing

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Who this might be right for
Cytomegalovirus Infection
Merck Sharp & Dohme LLC 220
Testing effectiveness (Phase 2)Ended earlyNCT03709576
What this trial is testing

Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Milton S. Hershey Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT01572376
What this trial is testing

Autologous Bone Marrow Stem Cells in Pressure Ulcer Treatment

Who this might be right for
Type IV Pressure UlcersChronic WoundsSpinal Cord Injury
Hospital Universitario Central de Asturias 30
Testing effectiveness (Phase 2)Study completedNCT02248597
What this trial is testing

Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases

Who this might be right for
Graft Versus Host DiseaseHematopoietic/Lymphoid Cancer
Wake Forest University Health Sciences 27
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06931613
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaChildrenNivolumab+1 more
St. Petersburg State Pavlov Medical University 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT05660824
What this trial is testing

Effectiveness of Stromal Vascular Fraction (SVF) and Platelet -Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Study Protocol for a Phase III, Prospective, Randomized, Controlled Multi-center Study.

Who this might be right for
Osteoarthritis
Adrien Schwitzguebel 108
Testing effectiveness (Phase 2)UnknownNCT01771679
What this trial is testing

Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging

Who this might be right for
Chronic Effect of Ultraviolet Radiation on Photoaged SkinDermatologic Disorders
Stemedica Cell Technologies, Inc. 29
Testing effectiveness (Phase 2)Ended earlyNCT01534143
What this trial is testing

High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Barbara Ann Karmanos Cancer Institute 1
Not applicableLooking for participantsNCT06225050
What this trial is testing

M-2018-334 in Hematological Malignancies

Who this might be right for
Hematological Malignancies
Miltenyi Biomedicine GmbH 18
Testing effectiveness (Phase 2)Study completedNCT03799718
What this trial is testing

Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS

Who this might be right for
Multiple Sclerosis, Chronic Progressive
Brainstorm-Cell Therapeutics 23
Testing effectiveness (Phase 2)Study completedNCT01883362
What this trial is testing

Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 60
Not applicableNot Yet RecruitingNCT07341178
What this trial is testing

Acute Effects on Stem Cell Surveillance

Who this might be right for
Stem Cell Surveillance
Natural Immune Systems Inc 48
Early research (Phase 1)Study completedNCT02195323
What this trial is testing

Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease
Royan Institute 7
Testing effectiveness (Phase 2)Study completedNCT02139280
What this trial is testing

Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy

Who this might be right for
Hematologic Malignancies
Dartmouth-Hitchcock Medical Center 58
Large-scale testing (Phase 3)Looking for participantsNCT06172296
What this trial is testing

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Who this might be right for
Ganglioneuroblastoma, NodularNeuroblastoma
National Cancer Institute (NCI) 478
Post-approval studies (Phase 4)Study completedNCT00001903
What this trial is testing

Prevention of RSV Infections in Bone Marrow Transplant Recipients

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 120
Next Page